ABBV Stock Recent News

ABBV LATEST HEADLINES

ABBV Stock News Image - fool.com

Many products sold by companies aren't must-have items. However, healthcare is a necessity.

fool.com 2025 Jan 21
ABBV Stock News Image - fool.com

You've probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case?

fool.com 2025 Jan 21
ABBV Stock News Image - fool.com

Investors seeking a steadily growing passive income stream want to turn their heads toward the healthcare sector. Unlike with enterprise software sales or consumer goods, spending on healthcare tends to move in a positive direction regardless of what's happening to the overall economy.

fool.com 2025 Jan 21
ABBV Stock News Image - seekingalpha.com

This article will reveal an in-depth analysis of drugs being developed to combat immunological disorders. Big Pharma is keenly interested in the global immunology drugs market, which is anticipated to exceed $190 billion by 2028. Every year, regulatory agencies approve dozens of biosimilars and brand-name drugs, so Seeking Alpha readers should be careful when making decisions.

seekingalpha.com 2025 Jan 19
ABBV Stock News Image - seekingalpha.com

Inflation continues to erode purchasing power, and recent volatility highlights the uncertainty in inflation trends. Despite this, long-term investors can still find opportunities. In an unpredictable environment, focusing on companies with resilient business models can provide stability. Coca-Cola, AbbVie, and TC Energy stand out in this regard. These stocks offer defensive growth, attractive dividends, and strong fundamentals. They're well-positioned to navigate inflation while providing consistent income and long-term returns.

seekingalpha.com 2025 Jan 17
ABBV Stock News Image - zacks.com

In the most recent trading session, AbbVie (ABBV) closed at $173.70, indicating a +1.37% shift from the previous trading day.

zacks.com 2025 Jan 16
ABBV Stock News Image - seekingalpha.com

AbbVie Inc. (NYSE:ABBV ) J.P. Morgan 43rd Annual Healthcare Conference January 15, 2025 11:15 AM ET Company Participants Rob Michael - Chief Executive Officer Scott Reents - Executive Vice President, Chief Financial Officer Jeff Stewart - Executive Vice President, Chief Commercial Officer Roopal Thakkar - Executive Vice President, Research & Development, Chief Scientific Officer Conference Call Participants Chris Schott - J.P.

seekingalpha.com 2025 Jan 15
ABBV Stock News Image - reuters.com

AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an industry conference on Wednesday.

reuters.com 2025 Jan 15
ABBV Stock News Image - seekingalpha.com

In December, I invested around $1,200 primarily in Business Development Companies, boosting my annual dividend income by $131 with a full-year total of almost $1,700.

seekingalpha.com 2025 Jan 15
ABBV Stock News Image - zacks.com

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.

zacks.com 2025 Jan 14
10 of 50